Abstract
Background Current cardiopulmonary resuscitation (CPR) guidelines recommend that chest compressions should be applied at “the center of the chest.” However, in approximately 50% of patients experiencing out-of-hospital cardiac arrest (OHCA) the aortic valve (AV) is reportedly compressed, potentially obstructing blood flow and worsening prognosis. We aimed to use resuscitative transesophageal echocardiography (TEE) to elucidate the impact of compressed vs. uncompressed AV on outcomes of adult patients experiencing OHCA.
Methods This prospective single-center observational cohort study included patients experiencing OHCA who underwent resuscitative TEE in the emergency department (ED). Exclusion criteria were early return of spontaneous circulation (ROSC) before TEE, resuscitative endovascular balloon occlusion of the aorta (REBOA) or extracorporeal membrane oxygenation (ECMO) initiation before ROSC, unidentifiable compression site, or poor quality/missing TEE images. Patients were divided into AV-compressed or uncompressed groups based on initial TEE findings. Documented patient characteristics, TEE recordings, resuscitation data, and critical time points were analyzed. Primary outcome was sustained ROSC. Secondary outcomes included end-tidal carbon dioxide (EtCO2) level at the 10th-minute post-ED arrival, any ROSC, survival to admission and discharge, active withdrawal post-resuscitation, and favorable neurological outcomes at discharge. Sample size was pre-estimated at 37 patients/group.
Results From October 2020 to January 2023, 76 patients were enrolled (39 and 37 patients in the AV-uncompressed and compressed groups, respectively). Intergroup baseline characteristics were similar. The AV-uncompressed group had better probability of sustained ROSC (53.8% vs. 24.3%, odds ratio [OR] 3.63, adjusted OR [aOR] 4.72, P=0.010), any ROSC (56.4% vs. 32.4%, OR 2.70, aOR 3.30, P=0.033), and survival to admission (33.3% vs. 8.1%, OR 5.67, aOR 6.74, P=0.010) than the AV-compressed group. The 10th-minute EtCO2 levels (16.0 vs. 14.0 mmHg), active withdrawal post-resuscitation (7.7% vs. 5.4%), and survival to discharge (5.1% vs. 0%) revealed no significant intergroup differences. No patient was discharged with favorable neurological outcomes. An uncompressed AV remained an essential factor for sustained ROSC across all predefined subgroups.
Conclusions Uncompressed AV during CPR increases the chances of ROSC and survival to admission among patients experiencing OHCA. However, its potential impact on long-term survival and neurological outcomes remains unclear.
Clinical Trial Registration This trial was registered at ClinicalTrials.gov, identifier NCT05932784. URL: https://clinicaltrials.gov/study/NCT05932784.
1) What is new?
When performing cardiopulmonary resuscitation according to the current guideline-recommended site, chest compressions may lead to accidental compression of the aortic valve (AV), which obstructs blood flow and worsens prognosis for patients experiencing out-of-hospital cardiac arrest.
We have used resuscitative transesophageal echocardiography to elucidate the impact of compressed vs. uncompressed AV on outcomes of these patients, a hitherto unexplored aspect.
Primary outcome was sustained return of spontaneous circulation (ROSC) and secondary outcomes included end-tidal carbon dioxide level at the 10th-minute post-emergency department arrival, any ROSC, survival to admission and discharge, active withdrawal post-resuscitation, and favorable neurological outcomes at discharge.
2) What are the clinical implications?
The AV-uncompressed group had a better chance of sustained ROSC, any ROSC, and survival to admission than the AV-compressed group.
However, its potential impact on long-term survival and neurological outcomes remains unclear; if resuscitative transesophageal echocardiography can be successfully used or if more convenient and lightweight tools can detect AV compression, both in prehospital situations, stronger evidence may be obtained.
Current cardiopulmonary resuscitation guidelines may need to be revised for a more individualized approach, which can help rescuers avoid accidental AV compression and improve patient outcomes and prognosis.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
This trial was an observational study registered at ClinicalTrials.gov, identifier NCT05932784. URL: https://clinicaltrials.gov/study/NCT05932784.
Funding Statement
This work was supported by the Far Eastern Memorial Hospital (Grant Number: PI20200001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Institutional Review Board (IRB) of the FEMH study (IRB number: 109070-F). The Declaration of Helsinki mandates informed consent for any study involving human participants. However, obtaining informed consent from unconscious patients is challenging when conducting cardiac arrest studies. To facilitate vital advancements in resuscitation science, the United States Food and Drug Administration has provided specific provisions for waiving informed consent in emergency medical research. Accordingly, the IRB approved this study including a waiver that was applicable regardless of the patients' survival or neurological recovery. Furthermore, the observational nature of this study and the routine use of resuscitative TEE at the FEMH's ED supported this waiver.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Non-standard Abbreviations and Acronyms
- AMC
- Area of Maximal Compression
- AoR
- Aortic root
- AV
- Aortic valve
- CCI
- Charlson Comorbidity Index
- ECPR
- Extracorporeal cardiopulmonary resuscitation
- EtCO2
- End-tidal Carbon Dioxide
- FEMH
- Far Eastern Memorial Hospital
- GEE
- Generalized estimating equations
- INL
- Inter-nipple line
- mRS
- Modified Rankin Scale
- N/A
- Not Applicable.
- OHCA
- Out-of-Hospital Cardiac Arrest
- REBOA
- Resuscitative Endovascular Balloon Occlusion of the Aorta
- ROSC
- Return of Spontaneous Circulation
- TEE
- Transesophageal Echocardiography
- TTM
- Target Temperature Management
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos